van der Lee M - Search Results

1

Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation.

Mosch R, van der Lee M, Guchelaar HJ, Swen JJ. Mosch R, et al. Among authors: van der lee m. Annu Rev Pharmacol Toxicol. 2024 Sep 30. doi: 10.1146/annurev-pharmtox-061724-080935. Online ahead of print. Annu Rev Pharmacol Toxicol. 2024. PMID: 39348848 Review.

2

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.

Knikman JE, Zhai Q, Lunenburg CATC, Henricks LM, Böhringer S, van der Lee M, de Man FM, Offer SM, Shrestha S, Creemers GJ, Baars A, Dezentjé VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, van Schaik RHN, Gelderblom H, Mathijssen RHJ, Schellens JHM, Cats A, Guchelaar HJ, Swen JJ. Knikman JE, et al. Among authors: van der lee m. Genome Med. 2024 Aug 15;16(1):101. doi: 10.1186/s13073-024-01354-z. Genome Med. 2024. PMID: 39148102 Free PMC article.

3

Resilience in the Face of Cancer: On the Importance of Defining and Studying Resilience as a Dynamic Process of Adaptation.

Schellekens MPJ, Zwanenburg LC, van der Lee ML. Schellekens MPJ, et al. Among authors: van der lee ml. Curr Oncol. 2024 Jul 12;31(7):4003-4014. doi: 10.3390/curroncol31070297. Curr Oncol. 2024. PMID: 39057169 Free PMC article. Review.

4

The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.

van Maaren MC, van Hoeve JC, Korevaar JC, van Hezewijk M, Siemerink EJM, Zeillemaker AM, Klaassen-Dekker A, van Uden DJP, Volders JH, Drossaert CHC, Siesling S; NABOR project group. van Maaren MC, et al. Support Care Cancer. 2024 May 2;32(5):323. doi: 10.1007/s00520-024-08530-2. Support Care Cancer. 2024. PMID: 38695938 Free PMC article.

5

Barriers and facilitators for healthy lifestyle and recommendations for counseling in endometrial cancer follow-up care: a qualitative study.

de Korte AM, de Rooij BH, Boll D, van Loon I, Vincent N, Hoedjes M, Lammens CRM, Mols F, van der Lee ML, Vos MC, Ezendam NPM. de Korte AM, et al. Among authors: van der lee ml. J Psychosom Obstet Gynaecol. 2024 Dec;45(1):2340465. doi: 10.1080/0167482X.2024.2340465. Epub 2024 Apr 15. J Psychosom Obstet Gynaecol. 2024. PMID: 38622864 Free article.

6

What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study.

Zwanenburg LC, van der Lee ML, Koldenhof JJ, Suijkerbuijk KPM, Schellekens MPJ. Zwanenburg LC, et al. Among authors: van der lee ml. Support Care Cancer. 2024 Mar 12;32(4):222. doi: 10.1007/s00520-024-08398-2. Support Care Cancer. 2024. PMID: 38470541 Free PMC article.

7

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients.

Zhai Q, Moes DJAR, van Gelder T, van der Lee M, Sanders JS, Bemelman FJ, de Fijter JW, Klein K, Schwab M, Swen JJ. Zhai Q, et al. Among authors: van der lee m. Clin Transl Sci. 2024 Feb;17(2):e13729. doi: 10.1111/cts.13729. Clin Transl Sci. 2024. PMID: 38380703 Free PMC article.

8

Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.

Klaassen-Dekker A, Drossaert CHC, Van Maaren MC, Van Leeuwen-Stok AE, Retel VP, Korevaar JC, Siesling S; NABOR project group. Klaassen-Dekker A, et al. BMC Cancer. 2023 Nov 14;23(1):1112. doi: 10.1186/s12885-023-11504-y. BMC Cancer. 2023. PMID: 37964214 Free PMC article.

9

Harmful communication behaviors in cancer care: A systematic review of patients and family caregivers perspectives.

Westendorp J, Geerse OP, van der Lee ML, Schoones JW, van Vliet MHM, Wit T, Evers AWM, van Vliet LM. Westendorp J, et al. Among authors: van der lee ml. Psychooncology. 2023 Dec;32(12):1827-1838. doi: 10.1002/pon.6247. Epub 2023 Nov 13. Psychooncology. 2023. PMID: 37957777 Review.

10

Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.

Feleus S, van der Lee M, Swen JJ, Roos RAC, de Bot ST. Feleus S, et al. Among authors: van der lee m. Ther Adv Rare Dis. 2023 Nov 8;4:26330040231204643. doi: 10.1177/26330040231204643. eCollection 2023 Jan-Dec. Ther Adv Rare Dis. 2023. PMID: 37955016 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters